First human tests for new diabetes pill in china
NCT ID NCT07073170
Summary
This early-stage study tested the safety and effects of a new oral medication called LY3549492 in Chinese adults with type 2 diabetes. Thirty-six participants took daily doses for about 18 weeks to see how their bodies handled the drug and whether it caused side effects. The main goal was to determine safe dosage levels before larger studies could test how well it controls blood sugar.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University First Hospital
Dongcheng District, 100009, China
-
Peking University People's Hospital
Beijing, 100033, China
-
West China Hospital of Sichuan University
Chengdu, 610041, China
Conditions
Explore the condition pages connected to this study.